Presentation: David Agus offers insights and access to breathtaking and powerful new technologies that promise to transform medicine in our generation. In the course of offering recommendations, he emphasises his belief that there is no “right” answer, no master guide that’s “one size fits all.” Each one of us must get to know our bodies in uniquely personal ways, and he shows us exactly how to do that so that we can individually create a plan to live longer. This groundbreaking approach will change not only how we care for ourselves, but also how we develop the next generation of treatments and cures.
About David Agus: One of the world’s leading doctors and pioneering biomedical researchers, over the past 20 years, Agus has received acclaim for his innovations in medicine and contributions to new technologies, which continue to change the perception of health and empower people around the world to maintain healthy lives. Agus is professor of medicine and engineering at the University of Southern California, where he leads USC’s Westside Cancer Centre and Centre for Applied Molecular Medicine. He serves as a CBS News contributor.
An international leader in new technologies and approaches for personalised healthcare, he cofounded two revolutionary companies: Navigenics and Applied Proteomics. Agus’ first book, The end of illness, was published in 2012 and is a New York Times No.1 and international bestseller, and subject of a PBS special. His second book, New York Times bestselling, A short guide to a long life, was published January 2014, and his newest book, The lucky years: How to thrive in the brave new world of health, was published January 2016.
Follow the 23rd CLSA Investors’ Forum on social media.